Encompass Health Corporation

EHC Healthcare Medical Care Facilities

Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.

Revenue
+8.93%
EPS
+20.6%
Free cash flow
+52.3%
Total debt
+6.83%

Quarter to September 2026, against a year earlier

137.55 3.72 −2.63%
Market cap
$13.9B
P/E
21.8×
Fwd P/E
20.9×
Dividend yield
0.55%
F-score
7/9
Altman Z
3.25
Beneish M
−2.71
Dividend safety
77/100

Encompass Health Corporation (EHC) EPS (diluted)

Alert me on EPS (diluted)

Encompass Health Corporation's EPS (diluted) for fiscal 2025 was $5.54, up 24.2% from $4.46 in fiscal 2024. Over the twelve months to 30 September 2026 it was $6.40. Over the past ten years it has ranged from $1.91 (fiscal 2015) to $5.54 (fiscal 2025) — the current reading is the highest in ten years. EPS (diluted) has risen for 3 consecutive fiscal years. Encompass Health Corporation ranks 9th of 48 Medical Care Facilities companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $5.54 24.22%
FY2024 $4.46 28.53%
FY2023 $3.47 28.52%
FY2022 $2.70 (34.31%)
FY2021 $4.11 44.21%
FY2020 $2.85 (21.05%)
FY2019 $3.61 23.21%
FY2018 $2.93 8.92%
FY2017 $2.69 3.86%
FY2016 $2.59 35.60%

Quarterly newest first

Period EPS (diluted) Change
Sep 2026 $1.50 (2.60%)
Jun 2026 $1.54 (20.21%)
Mar 2026 $1.93 34.97%
Dec 2025 $1.43 15.32%
43 more quarters

Against its own ten years

Low $1.91 High $5.54
Ten-year median $2.93
Current reading's percentile 100

EPS (diluted) against peers

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on EHC